Analysis and formulation development services, including consultation, for intranasal and inhalation drug products
Intertek Melbourn provides high quality cGMP analytical and formulation services to the pharmaceutical, biotech and healthcare industries. Our experienced team of analysts and formulation scientists offers method development, method validation, stability studies, expertise in inhaled products and other novel delivery systems, and a wide range of product formulation and testing services. Quality is at the heart of our business and we continue to invest in the latest equipment state of the art facilities to support our clients. This is proven time and again through regular audits from clients and the regulatory bodies including many successful FDA and MHRA inspections.
Bespak offers integrated services to support inhalation and nasal drug delivery; from initial combination device design, to formulation development, through to manufacturing. Our solutions span across the full product lifecycle, to help provide drug delivery devices to patients globally. These include pressurised metered dose inhalers (pMDIs), soft mist inhalers (SMIs) and multi dose and single dose nasal spray devices. Our experts have extensive knowledge throughout the entire lifecycle of drug product development to market, as well as accelerating routes to market. Bespak is your true expert CDMO partner for integrated inhalation and nasal platform offerings.
With over 30 years of inhalation product experience, Catalent Inhalation can handle the most complex projects and help bring orally inhaled and nasal therapies to market faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end expertise in dry powders for inhalation (DPI), as well as liquid and powder, unit-dose, bi-dose, and multi-dose nasal products.
Emmace Consulting offers excellence in performance testing and advising in development of Orally Inhaled and Nasal Drug Products on a CRO-basis. Our strengths are in the following arenas: • Traditional testing of inhalers (DPI, pMDI, and nebulizers) including cascade impaction, laser diffraction, and delivered dose uniformity characterization according to US and EU Pharmacopeias • Experimental determination of expected lung dose from inhalers by using anatomically realistic mouth-throat inlets in combination with patient-like inhalation profiles (best-in-class in-vitro/in-vivo comparisons) • Strategic advising in CMC and clinical support and in lung dose modeling • Software for the prediction of particle delivery to the lung — Mimetikos Preludium™
FLUIDDA is the leading R&D company in the field of quantitative image analysis. Its proprietary FRI technology – Functional Respiratory Imaging – offers a unique entry point into personalized medicine for patients suffering from respiratory diseases and sleep-related breathing disorders, by providing patient specific imaging biomarkers. Implementing FRI in early clinical research results in a cost-effective and time-saving screening of the most promising respiratory drugs.
MVIC is a CRO driving the future of inhaled medicine, we empower our partners with bespoke teams of unmatched expertise, streamlined processes, and unwavering commitment to innovation. Our experienced Project managers have supported development of blockbuster products from early phase to successful commercialization and will add value to you throughout the project’s lifespan. We specialize in Pre-formulation and tox, formulation, material science, analytical methods, automation and stability testing, device characterization, selection and design evaluation, preclinical PK/PD studies and phase 1/2 clinical studies. Please, reach out to us and find out how we can help your project.
Nanopharm is the leading provider of tailored analytical and product development of orally inhaled and nasal drug products (OINDPs). Our unique processing technologies and formulation development tools enable seamless translation of pre-clinical development through to clinical manufacture of OINDPs. Nanopharm’s integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics aids successful product development of OINDPs by understanding how material properties and processing conditions influence product functionality.
Testing under human realistic conditions determines “true” product performance and enables predictive In Vivo Correlation. By combining traditional Spray Pattern and Plume Geometry with the new INVIDA™ model, Proveris offers the most comprehensive view of OINDP testing available. For 25 years we have work closely with generic and branded pharmaceutical companies, device suppliers, and global regulatory agencies—serving as an extension of their development teams to assist in developing the right experiments and Proveris by Design™ process to evaluate data and optimize their OINDP development.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.